NCT04603183 2025-12-12
ABIGAIL
MedSIR
Phase 2 Completed
Clinical Trials
5 trialsNCT03328884 2025-04-23
Phenomenal
MedSIR
Phase 2 Completed
NCT03555877 2023-07-07
AMICA
GBG Forschungs GmbH
Phase 2 Completed
NCT02664103 2018-02-01
METRO-ABC
Sanofi
Phase 2 Completed
NCT00532714 2011-12-30
Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
National Cancer Center, Korea
Phase 2 Completed